Search Results - "Sugiyama, Aruto"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    High-throughput cytotoxicity and antigen-binding assay for screening small bispecific antibodies without purification by Sugiyama, Aruto, Umetsu, Mitsuo, Nakazawa, Hikaru, Niide, Teppei, Asano, Ryutaro, Hattori, Takamitsu, Kumagai, Izumi

    Published in Journal of bioscience and bioengineering (01-08-2018)
    “…The cytotoxicity of T cell-recruiting antibodies with their potential to damage late-stage tumor masses is critically dependent on their structural and…”
    Get full text
    Journal Article
  2. 2

    A semi high-throughput method for screening small bispecific antibodies with high cytotoxicity by Sugiyama, Aruto, Umetsu, Mitsuo, Nakazawa, Hikaru, Niide, Teppei, Onodera, Tomoko, Hosokawa, Katsuhiro, Hattori, Shuhei, Asano, Ryutaro, Kumagai, Izumi

    Published in Scientific reports (06-06-2017)
    “…Small bispecific antibodies that induce T-cell–mediated cytotoxicity have the potential to damage late-stage tumor masses to a clinically relevant degree, but…”
    Get full text
    Journal Article
  3. 3

    Association behavior and control of the quality of cancer therapeutic bispecific diabodies expressed in Escherichia coli by Nakazawa, Hikaru, Onodera-Sugano, Tomoko, Sugiyama, Aruto, Tanaka, Yoshikazu, Hattori, Takamitsu, Niide, Teppei, Ogata, Hiromi, Asano, Ryutaro, Kumagai, Izumi, Umetsu, Mitsuo

    Published in Biochemical engineering journal (15-08-2020)
    “…•Nearly half the LH diabody fraction and all the HL fraction were in inactive form.•Diabody fraction components changed dynamically with time.•The association…”
    Get full text
    Journal Article
  4. 4

    Recent research advances on non-linear phenomena in various biosystems by Tamaru, Yutaka, Nakanishi, Shuji, Tanaka, Kenya, Umetsu, Mitsuo, Nakazawa, Hikaru, Sugiyama, Aruto, Ito, Tomoyuki, Shimokawa, Naofumi, Takagi, Masahiro

    Published in Journal of bioscience and bioengineering (01-08-2023)
    “…All biological phenomena can be classified as open, dissipative and non-linear. Moreover, the most typical phenomena are associated with non-linearity,…”
    Get full text
    Journal Article
  5. 5

    Generation of camelid VHH bispecific constructs via in-cell intein-mediated protein trans-splicing by Shibuya, Yuki, Haga, Natsuki, Asano, Ryutaro, Nakazawa, Hikaru, Hattori, Takamitsu, Takeda, Daisuke, Sugiyama, Aruto, Kurotani, Reiko, Kumagai, Izumi, Umetsu, Mitsuo, Makabe, Koki

    Published in Protein engineering, design and selection (01-01-2017)
    “…Production of various combinations of bispecific variable domain of heavy chain of heavy chain-only antibody (VHH) constructs to evaluate their therapeutic…”
    Get full text
    Journal Article
  6. 6

    Compact Seahorse‐Shaped T Cell–Activating Antibody for Cancer Therapy by Fujii, Hiroto, Tanaka, Yoshikazu, Nakazawa, Hikaru, Sugiyama, Aruto, Manabe, Noriyoshi, Shinoda, Akira, Shimizu, Nobutaka, Hattori, Takamitsu, Hosokawa, Katsuhiro, Sujino, Takuma, Ito, Tomoyuki, Niide, Teppei, Asano, Ryutaro, Kumagai, Izumi, Umetsu, Mitsuo

    Published in Advanced therapeutics (01-07-2018)
    “…The vast information available on hierarchically structured proteins enables the creation of novel proteins with customized functions through the assembly of…”
    Get full text
    Journal Article